Seralutinib decreases endotrophin (PRO-C6) production, a mediator of fibrosis and inflammation, in an in vitro model of pulmonary fibrosis
Year: 2025
Type: conference-abstract
Source: European Respiratory Journal
Authors: Zhaoqing Ding, Mark Kuipers-Skarsfeldt, Robin Osterhout, Filipa B. Simões, Jannie Marie Bülow Sand, Lawrence S. Zisman, Sidra Hoffman, Robert F. Roscigno, Richard Aranda, Lawrence Ho, Ravikumar Sitapara, Eduardo Garcia, Anna R. Hemnes, Roham T. Zamanian, Bruno Guedes Baldi, Rogério Souza, Tomás Pulido, Morten Karsdal, Jean-Marie Bruey, Toby M. Maher
Institutions: Gossamer Bio (United States), Nordic Bioscience (Denmark), Vanderbilt University Medical Center, Stanford Medicine, Stanford University, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Instituto do Coração - HCFMUSP, Instituto Nacional de Cardiología, University of Southern California
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416635683